Who is sponsoring NCT01196845?

NCT01196845 is sponsored by University Hospital, Grenoble.

What drugs are being tested in NCT01196845?

Interventions in NCT01196845: cPAP, cPAP, cPAP, cPAP.

What condition does NCT01196845 study?

NCT01196845 studies Decrease of Inflammation of Adipose Tissue, Sleep Apnea Syndrome.

Is NCT01196845 still recruiting?

NCT01196845 is currently terminated. Last updated 29 December 2025.

Last reviewed 2025-12-29 · How we verify

NCT01196845: ADISAS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Inflammation and Oxidative Stress of Adipose Tissue in Sleep Apnea Syndrome

Terminated NA Last updated 29 December 2025

What this trial tests

NA trial testing cPAP in Decrease of Inflammation of Adipose Tissue in 40 participants. Terminated before completion.

Timeline

16 October 2010

Primary endpoint
16 February 2017

16 February 2017

Quick facts

Lead sponsor	University Hospital, Grenoble
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	basic science
Enrollment	40
Start date	16 October 2010
Primary completion	16 February 2017
Estimated completion	16 February 2017
Sites	1 location across France

Drugs / interventions tested

cPAP
cPAP
cPAP
cPAP

Conditions studied

Decrease of Inflammation of Adipose Tissue — all drugs for Decrease of Inflammation of Adipose Tissue →
Sleep Apnea Syndrome — all drugs for Sleep Apnea Syndrome →

Sponsor

University Hospital, Grenoble

Who can join

Adults 18 to 69, male only, with Decrease of Inflammation of Adipose Tissue or Sleep Apnea Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of this study is to evaluate the decrease of inflammation of adipose tissue in obese and non-obese patients having a sleep apnea syndrome and treated or not by continuous positive airway pressure (cPAP). An interim analysis will be performed when 40 patients will be included.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Impact of effective versus sham continuous positive airway pressure on liver injury in obstructive sleep apnoea: Data from randomized trials.
Jullian-Desayes I, Tamisier R, Zarski JP, Aron-Wisnewsky J, et al · · 2016 · cited 44× · PMID 26567858 · DOI 10.1111/resp.12672

Verify or expand the search:

Other University Hospital, Grenoble trials

Trials by the same sponsor.

NCT07479225 — Circulating Cell-Free DNA for Brain Abscess Diagnosis: A Pilot Study · NA · not yet recruiting
NCT07477613 — Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke · NA · not yet recruiting
NCT07379372 — Bladder Overactivity and Post-Botulinum Toxin Telemonitoring · NA · not yet recruiting
NCT07166991 — Anesthesia sTrategy foR Organ Procurement In braiN dEath · Phase 3 · recruiting
NCT07367880 — The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01196845 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Grenoble
Last refreshed: 29 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01196845.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing